Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

MRNA

+ Watchlist+ Portfolio

Moderna, Inc.

Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$206.80
52-Week Range
$22.28 – $280.80
Market Cap
$79.63B
P/E (TTM)
—
EPS (TTM)
-7.04
Dividend Yield
0.00%
Advanced Metrics
Price/Book
11.63
PEG Ratio
—
Return on Equity
-34.50%
Return on Assets
-9.96%
Gross Margin
-42.02%
Operating Margin
-80.79%
Profit Margin
-110.45%
Current Ratio
3.62
Debt/Equity
0.62
Total Debt
$4.23B
Free Cash Flow
$-584.50M
Revenue Growth
29.20%
Earnings Growth
—
Enterprise Value
$78.68B

Market Snapshot

About

Biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines. Known for developing one of the first COVID-19 vaccines. Works on treatments for infectious diseases, immuno-oncology, rare diseases, and cardiovascular conditions using mRNA technology.